Detalles de la búsqueda
1.
Therapeutic adherence and assessment of satisfaction patients with multiple myeloma treated with immunomodulatory drugs in a "real-world" study: Experiences of the Polish Myeloma Group.
J Oncol Pharm Pract
; : 10781552231203371, 2023 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37728209
2.
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.
Br J Haematol
; 198(1): 73-81, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35362096
3.
Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.
Am J Hematol
; 92(4): 359-366, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28103640
4.
Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
Biol Blood Marrow Transplant
; 21(5): 829-39, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25617806
5.
Beneficial effect of the CXCL12-3'A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors.
Cytokine
; 76(2): 182-186, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25982843
6.
NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(3): 409-14, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24345423
7.
Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.
Am J Hematol
; 89(10): E176-83, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25044365
8.
Comparing the Outcomes of Matched and Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation with Different Anti-Thymocyte Globulin Formulations: A Retrospective, Double-Centre Experience on Behalf of the Polish Adult Leukemia Group.
Cancers (Basel)
; 16(10)2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38791969
9.
Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in the Prophylaxis of Graft-Versus-Host Disease: A Systematic Review.
J Clin Med
; 12(17)2023 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37685516
10.
CD14 + HLADR - blood values in patients after alloHSCT are highly predictive of survival and infectious complications.
Transpl Immunol
; 65: 101370, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33484872
11.
CCR5 gene polymorphism affects the risk of GvHD after haematopoietic stem cell transplantation from an unrelated donor.
Br J Haematol
; 171(2): 285-288, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25823722
12.
Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma.
Adv Med Sci
; 64(2): 349-355, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31125864
13.
Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.
PLoS One
; 13(12): e0209108, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30521628
14.
The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.
PLoS One
; 13(1): e0190525, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29304116
15.
Intra-bone donor lymphocyte infusion at relapse: clinical outcome is associated with presence of CD8+ cells in the marrow.
Bone Marrow Transplant
; 55(5): 974-978, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31455896
16.
Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.
Viruses
; 7(3): 1391-408, 2015 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25807050
17.
Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study.
Leuk Lymphoma
; 56(8): 2331-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25393675
18.
Donor lymphocyte infusions to leukemic bone lesions are therapeutically effective in a Ph+ ALL patient with post-HSCT relapse.
J Immunotoxicol
; 11(4): 347-52, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24611731
Resultados
1 -
18
de 18
1
Próxima >
>>